5-fluorouracil
ABCC1
ABCG2
ATC code L01
Abemaciclib
Aclarubicin
Adagrasib
Adenomatosis polyposis coli
Adenosine deaminase inhibitor
Aflibercept
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Allergic reactions
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Anti-cancer medication
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Atropine
Axicabtagene ciloleucel
Azacitidine
Aziridine
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Bile duct
Bioavailability
Biological half-life
Bisantrene
Bleomycin
Blood clots
Bone marrow suppression
Bortezomib
Brexucabtagene autoleucel
Busulfan
Butyrylcholinesterase
CAS Registry Number
CYP3A4
CYP3A5
Cabazitaxel
Camptotheca
Camptotheca acuminata
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carboxylesterase 1
Carboxylesterase 2
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
Cell death
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
Colitis
Colon cancer
CompTox Chemicals Dashboard
Copanlisib
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA damage
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
DailyMed
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Diarrhea
Dicycloplatin
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug metabolism
Drug nomenclature
Drugs.com
Duvelisib
ECHA InfoCard
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Medicines Agency
Exatecan
Excretion
FOLFIRI
Farnesyltransferase inhibitor
Floxuridine
Fludarabine
Fluorouracil
Food and Drug Administration
Fotemustine
Fuzuloparib
Gemcitabine
Genetic testing
Gilbert's syndrome
Gimatecan
Glasdegib
Glucuronidation
Guide to Pharmacology
Halogenation
Hdl (identifier)
Health Canada
Histone deacetylase inhibitor
Homozygous
Hydrazine
Hydroxycarbamide
Hypomethylating agent
IMP dehydrogenase
ISBN (identifier)
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
International Chemical Identifier
Intravenous infusion
Intravenous therapy
Irinotecan
Irinotecan (data page)
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Kidney
Larotaxel
Leucovorin
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Liver
Lomustine
Lonidamine
Loperamide
Losoxantrone
Lucanthone
Lurbinectedin
Lurtotecan
M phase
Mannosulfan
Masoprocol
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
Multidrug resistance-associated protein 2
Nadofaragene firadenovec
National Center for Biotechnology Information
Navitoclax
Nedaplatin
Nelarabine
Neutropenia
Neutrophil
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
OCLC (identifier)
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Orphan drug
Ortataxel
Oxaliplatin
PARP inhibitor
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Pancreatic cancer
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacogenomics
Pharmacokinetics
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Pregnancy category
Prescription drug
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Public domain
Purine analogue
Pyrimidine analogue
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Romidepsin
Route of administration
Rubitecan
Rucaparib
SLCO1B1
SN-38
S phase
Satraplatin
Seliciclib
Selinexor
Semustine
Sex steroid
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Small cell lung cancer
Sotorasib
Spindle poison
Standard for the Uniform Scheduling of Medicines and Poisons
Streptomyces
Streptozotocin
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Thiopurine
Thiotepa
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
UDP glucuronosyltransferase 1 family, polypeptide A1
UGT1A1
UGT1A1*28
UGT1A10
UGT1A9
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vomiting
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
White blood cell
World Health Organization
Zorubicin